Genflow Biosciences PLC (LSE:GENF)
£ 0.0285 0 (0%) Market Cap: 9.97 Mil Enterprise Value: 9.28 Mil PE Ratio: 0 PB Ratio: 14.25 GF Score: 0/100

Genflow Biosciences PLC at OTC Markets Life Science Investor Forum Transcript

Jun 22, 2023 / 04:00PM GMT
Release Date Price: £0.0275 (-5.17%)
Eric May
OTC Markets Group - Moderator

Hello, and welcome to our virtual investor conferences. My name is Eric May. And on behalf of OTC Markets, we're very pleased you have joined us for our next slide presentation from Genflow Biosciences, a biotech company focused on developing gene therapies that target the aging process. (Event Instructions)

At this point, I'm very pleased to welcome Eric Leire, Founder and CEO of Genflow Biosciences PLC, which trades on the OTCQB Venture Market under the symbol GENFF and also on the LSE under the symbol GENF. Welcome, Eric.

Eric Leire
Genflow Biosciences PLC - CEO & Executive Director

Thank you, Eric. And thank you, the audience, for joining this presentation. I assume you won't be surprised if I make forward-looking statement, I can skip that and start presenting the company. Genflow is an anti-aging company. What does that mean? And you may be surprised to see a biotech company addressing aging. Aging is considered a fatality, not as a disease.

In fact, we should be very interested in aging.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot